Schedule 13G ownership disclosure

CHEMOMAB THERAPEUTICS LTD

American Depository Shares, each representing twenty (20) ordinary shares, no par value · CUSIP: 16385C104

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sphera Funds Management Ltd.

    Shares: 900,428 · Class: 4.78%

  • Sphera Global Healthcare GP Ltd.

    Shares: 900,428 · Class: 4.78%

  • Sphera Global Healthcare Management LP.

    Shares: 900,428 · Class: 4.78%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-25-001274
Form type
SCHEDULE 13G/A
Filer
Chemomab Therapeutics Ltd.
CIK
CIK 1534248
Filed
Apr 10, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub